TNF and breast cancer: Overall, using multiple approaches to investigate different subclusters/populations of TAMs and TIMs and validation using both transcriptomics and flow cytometry, we established that JHU083 treatment increases TNF signaling and overall inflammatory signaling, findings that are consistent with the previously reported findings in the 4T1 model of breast cancer (26).